Opendata, web and dolomites

INTENS SIGNED

INtestinal Tissue ENgineering Solution

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 INTENS project word cloud

Explore the words cloud of the INTENS project. It provides you a very rough idea of what is the project "INTENS" about.

syndrome    sbs    compromised    rates    uniquely    engineered    intestinal    survival    transplantation    cure    economic    hospitals    cell    groups    patients    surgery    disciplinary    short    reconstruction    bowel    scaffold    scientists    removed    nutrition    trial    complete    internationally    autologous    options    55    small    designed    infrastructure    preferred    sub    60    nutritional    transplant    entire    industry    occurs    biology    positioned    option    intestine    tissue    record    quality    renders    translation    90    regenerative    eminent    effort    shortage    offers    universities    lost    missing    public    avoiding    world    adults    engaging    engineering    functional    molecular    team    severe    rate    pn    respectively    intravenous    year    combination    organs    strategy    true    mortality    life    parenteral    function    clinical    possesses    expertise    basic    immunosuppression    overcoming    optimal    solution    source    track    patient    few    protocol    translate    incapable    solutions    medicine    ideal    combining    children    fulfilling   

Project "INTENS" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITY COLLEGE LONDON 

Organization address
address: GOWER STREET
city: LONDON
postcode: WC1E 6BT
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.intens.info/
 Total cost 7˙101˙716 €
 EC max contribution 5˙990˙464 € (84%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-PHC-2015-two-stage
 Funding Scheme RIA
 Starting year 2016
 Duration (year-month-day) from 2016-01-01   to  2020-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITY COLLEGE LONDON UK (LONDON) coordinator 1˙300˙713.00
2    KOBENHAVNS UNIVERSITET DK (KOBENHAVN) participant 921˙160.00
3    KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW NL (AMSTERDAM) participant 825˙625.00
4    CHILDREN'S HOSPITAL LOS ANGELES US (LOS ANGELES,CA) participant 810˙775.00
5    THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE UK (CAMBRIDGE) participant 720˙000.00
6    THE FRANCIS CRICK INSTITUTE LIMITED UK (LONDON) participant 682˙163.00
7    STEMCELL TECHNOLOGIES UK LTD UK (CAMBRIDGE) participant 629˙495.00
8    THE UNIVERSITY OF EDINBURGH UK (EDINBURGH) participant 100˙533.00
9    ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE CH (LAUSANNE) participant 0.00

Map

 Project objective

Short Bowel Syndrome (SBS) is a condition that occurs when part or the entire small intestine is missing or has been removed during surgery. This condition renders the bowel incapable of fulfilling its nutritional function (intestinal failure). There is no cure for SBS. Parenteral (intravenous) nutrition (PN) and bowel transplantation are currently the preferred options for nutrition in children and adults who have lost their bowel. PN offers a low survival rate, compromised quality of life, and the economic cost for each patient is estimated to be 55,000 euro/year. Small intestinal transplant is also an option with one-year and 4-year survival rates of 90% and 60% respectively. However, because of the shortage of organs, high mortality, the severe side effects of immunosuppression and low quality of life, this is still a sub-optimal solution. The objective of this programme is to deliver a functional bowel reconstruction to patients with SBS through an autologous tissue engineering strategy, overcoming the shortage of organs, and avoiding the need for immunosuppression. It will be achieved by identifying the best autologous cell source; providing the ideal scaffold; engineering functional intestine for transplantation and engaging with patients, scientists and public. The work is designed to lead directly to a clinical trial for the application of the optimal protocol for tissue-engineered intestine. The consortium is uniquely positioned to complete this ambitious effort as we have an internationally pre-eminent, multi-disciplinary team, which possesses a combination of expertise from basic molecular biology, engineering, and surgery, combining knowledge from universities, hospitals and industry. Importantly we are one of the few groups in the world with experience, infrastructure, and track record to translate regenerative medicine solutions to patients, including true clinical translation of tissue engineered organs.

 Deliverables

List of deliverables.
Obtaining tissue Documents, reports 2020-02-03 16:27:04
Tool for engaging the public Other 2020-02-03 16:27:04
Website Websites, patent fillings, videos etc. 2020-02-03 16:27:03

Take a look to the deliverables list in detail:  detailed list of INTENS deliverables.

 Publications

year authors and title journal last update
List of publications.
2018 Shiro Yui, Luca Azzolin, Martti Maimets, Marianne Terndrup Pedersen, Robert P. Fordham, Stine L. Hansen, Hjalte L. Larsen, Jordi Guiu, Mariana R.P. Alves, Carsten F. Rundsten, Jens V. Johansen, Yuan Li, Chris D. Madsen, Tetsuya Nakamura, Mamoru Watanabe, Ole H. Nielsen, Pawel J. Schweiger, Stefano Piccolo, Kim B. Jensen
YAP/TAZ-Dependent Reprogramming of Colonic Epithelium Links ECM Remodeling to Tissue Regeneration
published pages: 35-49.e7, ISSN: 1934-5909, DOI: 10.1016/j.stem.2017.11.001
Cell Stem Cell 22/1 2020-02-03
2018 Giuliana Rossi, Andrea Manfrin, Matthias P. Lutolf
Progress and potential in organoid research
published pages: 671-687, ISSN: 1471-0056, DOI: 10.1038/s41576-018-0051-9
Nature Reviews Genetics 19/11 2020-02-03
2018 Alfonso Martinez Arias, Matthias P. Lutolf
Mammalian body plan engineering: Lessons and challenges
published pages: 50-56, ISSN: 2452-3100, DOI: 10.1016/j.coisb.2018.07.007
Current Opinion in Systems Biology 11 2020-02-03
2017 Yoji Tabata, Matthias P. Lutolf
Multiscale microenvironmental perturbation of pluripotent stem cell fate and self-organization
published pages: , ISSN: 2045-2322, DOI: 10.1038/srep44711
Scientific Reports 7/1 2020-02-03

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "INTENS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "INTENS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

VANGUARD (2020)

New Generation Cell Therapy: Bioartificial Pancreas to Cure Type 1 Diabetes

Read More  

AutoCRAT (2020)

Automated Cellular Robot-Assisted Technologies for translation of discovery-led research in Osteoarthritis

Read More  

ISLET (2020)

Advancing Innovative Stem Cell-based Therapy for Diabetes in Europe

Read More